compounds rh npa (Dojindo Labs)
Dojindo Labs is a verified supplier 
Dojindo Labs manufactures this product 
99
Structured Review
Dojindo Labs
compounds rh npa
Compounds Rh Npa, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 99/100, based on 59848 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compounds+rh+npa/Cell+Counting+Kit-8/10__1016_slash_j__dyepig__2025__113519-107-37-44
Average 99 stars, based on 59848 article reviews
Compounds Rh Npa, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 99/100, based on 59848 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compounds+rh+npa/Cell+Counting+Kit-8/10__1016_slash_j__dyepig__2025__113519-107-37-44
Average 99 stars, based on 59848 article reviews
compounds rh npa - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Cell Culture:Article Title: Long–term kinetic profiling of legumain–activated fluorescent probes and identification of a legumain substrate for cleavable linker design Article Snippet: Legumain, a cysteine protease involved in critical biological processes, such as protein degradation, antigen processing, and apoptosis, has been implicated in various diseases, including cancer and Alzheimer’s disease.. Its elevated expression in tumors compared to normal tissues makes legumain a promising target for cancer therapy.. Legumain–activated prodrugs and ligand-targeted drugs (LTDs), including antibody–drug conjugates (ADCs) designed to release therapeutic payloads specifically in tumor tissues via legumain proteolytic activity, have garnered significant attention and are currently under extensive investigation. CCK-8 Assay:Article Title: Long–term kinetic profiling of legumain–activated fluorescent probes and identification of a legumain substrate for cleavable linker design Article Snippet: Legumain, a cysteine protease involved in critical biological processes, such as protein degradation, antigen processing, and apoptosis, has been implicated in various diseases, including cancer and Alzheimer’s disease.. Its elevated expression in tumors compared to normal tissues makes legumain a promising target for cancer therapy.. Legumain–activated prodrugs and ligand-targeted drugs (LTDs), including antibody–drug conjugates (ADCs) designed to release therapeutic payloads specifically in tumor tissues via legumain proteolytic activity, have garnered significant attention and are currently under extensive investigation. |